BBOTVSERAS• 6 Months (Normalized)
BBOT vs ERAS (BridgeBio Oncology Therapeutics Inc. vs Erasca Inc.)
Showing Closing Date Range from Apr 5 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-56.34%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
ERAS Performance $14.74
-13.9%
Erasca Inc.
Normalized Baseline0.00%
Alpha Spread Margin ERAS LEADS
-42.44 pts
ERAS outperforming by 42.44 percentage points
BBOTERAS
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT ERAS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(125 dates)
| Date | BBOT Price | BBOT Gain (%) | ERAS Price | ERAS Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -56.34% | $14.74 | -13.90% | -42.44% |
| Sep 30, 2026 | $4.10 | -53.98% | $- | - | |
| Sep 29, 2026 | $3.92 | -56.00% | $- | - | |
| Sep 28, 2026 | $3.81 | -57.24% | $14.13 | -17.46% | -39.78% |
| Sep 25, 2026 | $3.95 | -55.67% | $14.25 | -16.76% | -38.91% |
| Sep 24, 2026 | $3.99 | -55.22% | $14.52 | -15.19% | -40.03% |
| Sep 23, 2026 | $4.16 | -53.31% | $13.95 | -18.55% | -34.76% |
| Sep 22, 2026 | $4.66 | -47.70% | $15.55 | -9.17% | -38.53% |
| Sep 21, 2026 | $4.66 | -47.70% | $15.04 | -12.15% | -35.55% |
| Sep 18, 2026 | $4.77 | -46.46% | $14.77 | -13.73% | -32.73% |
| Sep 17, 2026 | $4.89 | -45.12% | $15.34 | -10.40% | -34.72% |
| Sep 16, 2026 | $4.76 | -46.58% | $15.36 | -10.28% | -36.30% |
| Sep 15, 2026 | $4.88 | -45.23% | $16.25 | -5.08% | -40.15% |
| Sep 14, 2026 | $5.05 | -43.32% | $16.16 | -5.61% | -37.71% |
| Sep 11, 2026 | $4.95 | -44.44% | $15.88 | -7.24% | -37.20% |
Page 1 of 9